Shockwave Inventory vs Other Current Liab Analysis
SWAV Stock | USD 330.13 0.75 0.23% |
Shockwave Medical financial indicator trend analysis is much more than just breaking down Shockwave Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Shockwave Medical is a good investment. Please check the relationship between Shockwave Medical Inventory and its Other Current Liab accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shockwave Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Shockwave Stock please use our How to Invest in Shockwave Medical guide.
Inventory vs Other Current Liab
Inventory vs Other Current Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Shockwave Medical Inventory account and Other Current Liab. At this time, the significance of the direction appears to have totally related.
The correlation between Shockwave Medical's Inventory and Other Current Liab is 1.0. Overlapping area represents the amount of variation of Inventory that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Shockwave Medical, assuming nothing else is changed. The correlation between historical values of Shockwave Medical's Inventory and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Inventory of Shockwave Medical are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Inventory i.e., Shockwave Medical's Inventory and Other Current Liab go up and down completely randomly.
Correlation Coefficient | 1.0 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Inventory
Other Current Liab
Most indicators from Shockwave Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Shockwave Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shockwave Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Shockwave Stock please use our How to Invest in Shockwave Medical guide.At this time, Shockwave Medical's Tax Provision is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 100 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.12 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 196.6M | 300.6M | 468.8M | 492.3M | Cost Of Revenue | 41.4M | 65.0M | 95.4M | 100.2M |
Shockwave Medical fundamental ratios Correlations
Click cells to compare fundamentals
Shockwave Medical Account Relationship Matchups
Shockwave Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 231.9M | 272.0M | 345.7M | 646.1M | 1.6B | 1.6B | |
Other Current Liab | 13.8M | 19.9M | 40.9M | 55.4M | 91.7M | 96.3M | |
Total Current Liabilities | 24.0M | 25.6M | 51.6M | 63.4M | 104.2M | 109.4M | |
Total Stockholder Equity | 192.7M | 225.7M | 241.8M | 511.3M | 668.7M | 702.1M | |
Net Tangible Assets | 192.7M | 225.7M | 241.8M | 511.3M | 588.0M | 617.4M | |
Property Plant And Equipment Net | 13.7M | 23.9M | 51.9M | 80.5M | 98.6M | 103.6M | |
Net Debt | (116.3M) | (25.4M) | (42.0M) | (96.2M) | 442.2M | 464.3M | |
Retained Earnings | (178.0M) | (243.7M) | (252.8M) | (36.8M) | 110.5M | 116.0M | |
Accounts Payable | 2.8M | 1.5M | 3.5M | 6.7M | 8.9M | 9.3M | |
Cash | 139.0M | 50.4M | 89.2M | 156.6M | 328.4M | 344.8M | |
Non Current Assets Total | 15.2M | 25.7M | 59.8M | 186.8M | 341.3M | 358.4M | |
Non Currrent Assets Other | 56K | 362K | 1.9M | 5.2M | 8.0M | 8.4M | |
Other Assets | 1.5M | 9.4M | 1.9M | 102.8M | 118.2M | 124.1M | |
Cash And Short Term Investments | 195.3M | 202.4M | 201.0M | 304.5M | 990.6M | 1.0B | |
Net Receivables | 7.4M | 11.7M | 37.4M | 71.4M | 114.6M | 120.3M | |
Common Stock Shares Outstanding | 23.9M | 33.1M | 35.1M | 37.9M | 38.2M | 33.7M | |
Short Term Investments | 56.3M | 151.9M | 111.8M | 147.9M | 662.1M | 695.2M | |
Liabilities And Stockholders Equity | 231.9M | 272.0M | 345.7M | 646.1M | 1.6B | 1.6B | |
Non Current Liabilities Total | 15.3M | 20.8M | 52.2M | 71.4M | 793.7M | 833.4M | |
Capital Surpluse | 4.3M | 370.6M | 469.3M | 494.8M | 569.0M | 295.1M | |
Inventory | 12.1M | 29.9M | 43.0M | 75.1M | 107.6M | 113.0M | |
Other Current Assets | 1.9M | 2.4M | 4.5M | 8.3M | 12.6M | 13.2M | |
Other Stockholder Equity | 138.6M | 469.3M | 494.8M | 549.0M | 557.9M | 372.3M | |
Total Liab | 39.3M | 46.4M | 103.9M | 134.8M | 897.9M | 942.8M | |
Net Invested Capital | 206.5M | 242.3M | 259.0M | 535.5M | 1.4B | 1.5B | |
Property Plant And Equipment Gross | 13.7M | 16.4M | 51.9M | 80.5M | 115.7M | 121.5M | |
Total Current Assets | 216.7M | 246.3M | 285.9M | 459.3M | 1.2B | 1.3B | |
Accumulated Other Comprehensive Income | 35K | 9K | (202K) | (867K) | 293K | 307.7K | |
Net Working Capital | 192.7M | 220.7M | 234.3M | 395.9M | 1.1B | 1.2B | |
Common Stock | 21K | 31K | 35K | 36K | 37K | 31.0K | |
Property Plant Equipment | 13.7M | 16.4M | 51.9M | 80.5M | 92.6M | 97.2M | |
Short Long Term Debt Total | 22.7M | 25.0M | 47.2M | 60.4M | 770.6M | 809.1M | |
Long Term Debt | 7.2M | 13.3M | 11.6M | 24.2M | 731.9M | 768.5M | |
Short Term Debt | 7.4M | 4.2M | 7.2M | 1.3M | 3.6M | 3.4M |
Pair Trading with Shockwave Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Shockwave Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shockwave Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Shockwave Stock
0.87 | DOCS | Doximity Upward Rally | PairCorr |
0.74 | ENSG | Ensign Group | PairCorr |
0.71 | VEEV | Veeva Systems Class Financial Report 29th of May 2024 | PairCorr |
0.64 | CNC | Centene Corp | PairCorr |
0.62 | CVS | CVS Health Corp | PairCorr |
The ability to find closely correlated positions to Shockwave Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Shockwave Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Shockwave Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Shockwave Medical to buy it.
The correlation of Shockwave Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Shockwave Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Shockwave Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Shockwave Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shockwave Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Shockwave Stock please use our How to Invest in Shockwave Medical guide.Note that the Shockwave Medical information on this page should be used as a complementary analysis to other Shockwave Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Shockwave Stock analysis
When running Shockwave Medical's price analysis, check to measure Shockwave Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shockwave Medical is operating at the current time. Most of Shockwave Medical's value examination focuses on studying past and present price action to predict the probability of Shockwave Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shockwave Medical's price. Additionally, you may evaluate how the addition of Shockwave Medical to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Shockwave Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shockwave Medical. If investors know Shockwave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shockwave Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.398 | Earnings Share 4.26 | Revenue Per Share 21.342 | Quarterly Revenue Growth 0.358 | Return On Assets 0.0868 |
The market value of Shockwave Medical is measured differently than its book value, which is the value of Shockwave that is recorded on the company's balance sheet. Investors also form their own opinion of Shockwave Medical's value that differs from its market value or its book value, called intrinsic value, which is Shockwave Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shockwave Medical's market value can be influenced by many factors that don't directly affect Shockwave Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shockwave Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Shockwave Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shockwave Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.